Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease

Review

“…provides the reader with extensive and profound information about this new class, based on data from completed and ongoing trials…can be recommended not only to cardiologists but to all clinicians and researchers interested in this field.” -Intensive Care Medicine

Product Description

The Cleveland Clinic Foundation, OH. Text provides a comprehensive overview of the clinical development of the class of glycoprotein IIb/IIIa receptor antagonists. Includes new information from trials using glycoprotein and its role in coronary vascular disease and acute coronary syndromes. Previous edition: c1999. DNLM: Cardiovascular Diseases.

Buy Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease at Amazon
Buy Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease at Amazon

Women have ’same heart symptoms’ (news.bbc.co.uk)
Coronary imaging techniques helps to identify plaques likely to cause heart attacks (scienceblog.com)
Oct. 30, 1958: Medical Oops Leads to First Coronary Angiogram (lifetoup.com)
Study finds women slightly more likely to die than men in the 30 days following a heart attack (scienceblog.com)
Why heart attacks, chest pain seem to hit women harder (cbc.ca)
Have You Had Your Omega-3 Today? (abcnews.go.com)
Another Question Answered ” AVERT-IT (avantrasara.com)
Black patients experience worse cardiac care, lower survival rates (scienceblog.com)
Sight gone, but not necessarily lost? (scienceblog.com)
Ya gotta have heart… (daisyfae.wordpress.com)

No Related Posts

This entry was posted on Tuesday, November 10th, 2009 at 10:52 am and is filed under smoking cardiovascular disease. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.